Q1 2023 Holdings
Filed 2023-05-15 | 36 holdings | $695.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $214.4M | 3,250,000 | 30.8% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $59.1M | 2,551,703 | 8.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $49.6M | 2,468,000 | 7.1% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $39.9M | 4,570,918 | 5.7% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $39.6M | 2,172,000 | 5.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $30.1M | 1,185,000 | 4.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $28.8M | 3,904,000 | 4.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $27.9M | 750,000 | 4.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $27.3M | 759,898 | 3.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $22.2M | 1,338,160 | 3.2% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $19.3M | 474,929 | 2.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $12.5M | 621,712 | 1.8% |
| Jasper Therapeutics Inc | COM | 471871103 | $11.6M | 6,382,500 | 1.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $11.1M | 495,000 | 1.6% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $9.3M | 1,202,000 | 1.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $8.6M | 499,996 | 1.2% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $8.1M | 596,000 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $8.0M | 692,945 | 1.1% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.7M | 2,425,000 | 1.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.2M | 375,000 | 0.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $6.2M | 795,000 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $6.1M | 400,000 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $5.9M | 382,000 | 0.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.1M | 94,700 | 0.7% |
| Geron Corp(GERN) | COM | 374163103 | $4.9M | 2,278,000 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.7M | 577,000 | 0.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.6M | 1,190,000 | 0.7% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $3.8M | 3,000,000 | 0.5% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $2.5M | 420,000 | 0.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.5M | 1,958,069 | 0.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.2M | 93,692 | 0.3% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $1.7M | 100,000 | 0.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.5M | 185,669 | 0.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.5M | 396,000 | 0.2% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $300.1K | 35,259 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $294.3K | 301,490 | 0.0% |